CRISPR Screening at Scale

Achieving 1M cell data sets with an instrument-free, cost-effective approach

Darina Šikrová Researcher, Molecular Biology Single Cell Discoveries

Melanie Masuda, Director of Market Development, Scale Biosciences

Genome-wide CRISPR screens are becoming the standard for drug discovery to power unbiased identification of drug targets across gene regulatory networks. Requiring single-cell genomics as the data output, these experiments can easily reach millions of cells in a single screen. In this webinar presented by Drug Discovery World, Single Cell Discoveries will present data on how it was able to use ScaleBio’s technology to perform single-cell RNA sequencing with guide capture on 1M cells from a genome-wide perturbation screen.